US Stocks

Catalent, Inc.

Catalent, Inc. develops and manufactures drug solutions, protein-based biologics, cell and gene therapies, and consumer health products. The company operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. It provides customized manufacturing and clinical supply services to pharmaceutical, biotechnology, and consumer health companies.